Indonesian Journal of Cancer Chemoprevention
Vol 3, No 2 (2012)

Hesperidin Increases Cytotoxic Effect of 5-Fluorouracil on WiDr Cells

Yurista Gilang (Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada)
Adam Hermawan (Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada)
Aditya Fitriasari (Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada)
Riris Istighfari Jenie (Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada)



Article Info

Publish Date
30 Jun 2012

Abstract

Therapy of colon cancer by using 5-FU often causes problems of resistance. This encourages the development of co-chemotherapy agent. One of the compounds that could potentially be used as a co-chemotherapy agent is hesperidin. This study was conducted to determine the cytotoxic effects of hesperidin, 5-FU and the combination of them, as well as apoptosis induction in colon cancer cells WiDr. Cytotoxic effect of hesperidin, 5-FU, and its combination were observed using MTT assay. Observation of apoptosis was done by double staining method using ethidium bromide-acridin orange. Until 48 hours incubation, hesperidin showed no cytotoxic effects. Cytotoxic effects of 5-FU was observed after 48 hours with the IC50 value of 422 µM. However, hesperidin improved the cytotoxic effects of 5-FU at 48 hour incubation. Either single treatment of hesperidin 200µM or 5-FU 1500 µM did not trigger apoptosis, but combination of them led to the emergence of signs of apoptosis. Based on this study,it can be concluded thathesperidin is potential to be developed as a co-chemotherapy agent of 5-FU on colon cancer but still need further study on its molecular mechanisms.Keywords : hesperidin, 5-fluorouracil, WiDr cells, cytotoxic, apoptosis

Copyrights © 2012






Journal Info

Abbrev

ijcc

Publisher

Subject

Biochemistry, Genetics & Molecular Biology Medicine & Pharmacology

Description

Indonesian Journal of Cancer Chemoprevention (IJCC) is an open access, peer-reviewed, triannual journal devoted to publishing articles on Cancer Chemoprevention including Experimental and Clinical Pharmacology, especially concerning Anti-Oxidants, Anti-Aging, Anti-Inflammation, Anti-Angiogenesis, ...